Rodríguez-Cabello José Carlos, Piña María Jesús, Ibáñez-Fonseca Arturo, Fernández-Colino Alicia, Arias Francisco Javier
BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, University of Valladolid, 47011 Valladolid, Spain.
Bioconjug Chem. 2015 Jul 15;26(7):1252-65. doi: 10.1021/acs.bioconjchem.5b00183. Epub 2015 Jun 5.
This Review discusses the use of elastin-like polymers and their recombinant version, elastin-like recombinamers, in drug-delivery systems. These macromolecules exhibit a number of interesting properties that are rarely found together in any other family of materials, especially extremely high biocompatibility, high bioactivity and functionality, complex yet fully controlled composition, and stimuli responsiveness. Appropriate design of these molecules opens up a broad range of different possibilities for their use in new therapeutic platforms. The first of these described herein is the use of ELRs in single-molecule devices as therapeutic entities in their own right. Subsequently, we describe how the self-assembly properties of these materials can be exploited to create nanocarriers and, eventually, microcarriers that are able to temporally and spatially control and direct the release of their drug load. Intracellular drug-delivery devices and nanocarriers for treating cancer are among the uses described in that section. Finally, the use of ELRs as base materials for implantable drug depots, in the form of hydrogels, is discussed.
本综述讨论了弹性蛋白样聚合物及其重组形式——弹性蛋白样重组聚合物在药物递送系统中的应用。这些大分子具有许多有趣的特性,在任何其他材料家族中都很少同时出现,尤其是极高的生物相容性、高生物活性和功能性、复杂但完全可控的组成以及刺激响应性。对这些分子进行适当设计,为其在新型治疗平台中的应用开辟了广泛的不同可能性。本文首先描述的是将弹性蛋白样重组聚合物用作单分子装置,其本身即为治疗实体。随后,我们阐述了如何利用这些材料的自组装特性来制备纳米载体,并最终制备出能够在时间和空间上控制和引导其药物负载释放的微载体。该部分所述的用途包括用于治疗癌症的细胞内药物递送装置和纳米载体。最后,讨论了将弹性蛋白样重组聚合物用作水凝胶形式的可植入药物储库的基础材料。